Sernova Corp (TSE:SVA) has released an update.
Sernova Corp has announced the appointment of interim CFO Nicholas J. Rossettos, while actively seeking a permanent CFO and other key leadership positions to advance its strategic goals. The company is dealing with internal investigations, resulting in the termination of previous CFO David Swetlow for cause, but confirms these issues will not materially affect financial statements. Sernova continues to innovate in regenerative medicine, aiming to transform patient lives with their Cell Pouch System and partnerships for cell therapy treatments.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
